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Introduction: About 30% of neonates develop thrombocytopenia during hospital admission. Inevitable and 
irreversible complications can be prevented by determining the risk factors of neonatal thrombocytopenia. The 
present study was undertaken to determine the risk factors and outcome of neonatal thrombocytopenia in 
neonates admitted to Neonatal Intensive Care Unit Benazir Bhutto Hospital Rawalpindi. 
Materials and Methods: A prospective study was conducted to evaluate the risk factors for neonatal 
thrombocytopenia (NT) in 160 neonates. Neonatal and maternal risk factors were recorded and neonates were 
categorized into three groups based on the severity of thrombocytopenia. 
Results: A higher percentage of the neonates 89 (55.6%) were male. The majority (61.9%) had moderate neonatal 
thrombocytopenia while 21.9% had severe neonatal thrombocytopenia. A highly significant difference was 
observed for the distribution of gestational age, platelet count, birth weight, and age at admission (for all p-value 
≥0.0001) among different groups. Multivariate logistic regression revealed a significant independent association of 
prematurity, birth asphyxia, and low birth weight with neonatal thrombocytopenia. 
Conclusion: Prematurity, low birth weight, and birth asphyxia were the significant causes of Neonatal 
thrombocytopenia. The mortality rate increased significantly with the severity of thrombocytopenia.  
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Introduction 
 
Platelets are non-nucleated tiny cellular fragments 
produced in the bone marrow as a result of 
cytoplasmic fragmentation of megakaryocytes.1 
Platelet production in the fetus starts around 5th week 
of gestational age. By the end of the second trimester, 
the fetus has platelet count in the normal range of 150 
to 450 × 109/L.2 Platelet count below 150 × 109/L in 
neonates is defined as Neonatal 
Thrombocytopenia(NT).3 Thrombocytopenia might 
develop during fetal life and neonates are presented 
with decreased platelet count at birth. A higher 
prevalence rate (18–35%) of NT is observed in 
premature neonates as compared to.2% of full-term 
neonates.4 Depending on the population being 
studied, there could be variation in the incidence of 
thrombocytopenia. Several fatal conditions like low 
birth weight, prematurity, sepsis, birth asphyxia, 
hypotension, exchange transfusion, and some maternal 
conditions like hypertension can cause 
thrombocytopenia in newborns. 
The chances of developing thrombocytopenia rise with 
a degree of prematurity.5 Similarly, a negative 
association between birth weight and 
thrombocytopenia is reported. Low-birth weight 
neonates had a 2.52-fold higher risk for developing 
thrombocytopenia.6,7 Gestational hypertension is 
another important risk factor contributing to NT. The 
rate and severity of thrombocytopenia in neonates of 
mothers suffering from gestational hypertension vary. 
Among the neonates born to mothers with gestational 
hypertension, the prevalence of NT differs extensively 
from 9.2 to 36%.8,9 
This study aims at finding thrombocytopenia and its 
associated risk factors in the NICU and outcome of NT 
in terms of mortality, improvement, and 
intraventricular hemorrhage. 
 
Materials and Methods 
 
A prospective study was conducted at the Department 
of NICU, Benazir Bhutto Hospital, and Rawalpindi 
from July 2018 to January 2019. The sample size of 160 
was calculated according to WHO criteria.  
Inclusion Criteria: Neonates with thrombocytopenia 
admitted to NICU. Both genders were included. 
Exclusion Criteria: Neonates with congenital 
anomalies, twin babies, and those whose parents did 
not give the consent were excluded from the study 
After informed written consent from parents, the 
neonates meeting inclusion criteria, born between July 
2018 and January 2019 at the Department of Pediatrics 
Benazir Bhutto Hospital were enrolled in the study. 
The study was approved by the ethics committee of 
Rawalpindi Medical University. The severity of 
thrombocytopenia was categorized as follows: mild, a 
platelet count of 100,000 to 150,000/μL; moderate, a 
platelet count of 50,000 to < 100,000/μL; severe, a 
platelet count of 30,000 to <50,000/μL10. Based on the 
time of onset NT has been grouped into two classes 
early-onset (EOT), which is within 72 h of life, and 
late-onset (LOT), after 72 h of life.11,12 Asphyxia was 
defined according to the Statement of the American 
College of Obstetricians and Gynecologists.13 
Two ml of blood was collected aseptically in EDTA 
containing tubes. Giving due credence to neonates’ 
condition and difficulty in sample collection 
appropriate volume adjustments were incorporated as 
automated Hematology analyzers can measure for less 
volume. The tubes were kept on a roller mixer for 10 
minutes to ensure proper mixing. As a quality control 
measure, a thin smear of each sample was made and 
stained with field stain. Light microscopy of the 
stained film was done to rule out platelet clumps and 
to ensure even dispersion of platelets.  This practice 
eliminated the possibility of false low platelet count. 
Enrolled neonates were observed prospectively and 
platelet count was done at presentation and 
subsequently as and when required with sysmex. All 
reports were verified by the Consultant Hematologist 
and risk factors associated with thrombocytopenia 
were assessed. Study participants were followed for a 
one-month duration to see the outcome of 
improvement, intraventricular hemorrhage, and 
mortality. 
Statistical Analysis: Data was analyzed using SPSS 
version 25.0. Mean ± SD were calculated for 
gestational age, birth weight, and platelet count. 
Kruskal Wallis test, a nonparametric alternative to 
one-way ANOVA was used to compare the 
continuous variable. Categorical variables were 
compared by the χ2 test. The frequency of associated 
risk factors and outcomes of neonatal 
thrombocytopenia were calculated. Effect modifiers 
like gender and severity of thrombocytopenia were 
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Results 
 
The majority of neonates had moderate NT with early-
onset (83.1%). Prematurity, low birth weight, neonatal 
jaundice, gestational hypertension, and birth asphyxia 
were the commonest risk factors (Table 1). A highly 
significant difference was observed for the distribution 
of gestational age, platelet count, birth weight, and age 
at admission (for all p-value ≥ 0.0001) among different 
NT groups (Table 2). No significant difference was 
observed for the prevalence of birth asphyxia (χ2=1.65; 
p-value=0.438) among different NT groups. 
In multivariate regression analysis, prematurity, birth 
Asphyxia, and low birth weight showed a significant 
independent association with NT. (Table 4) 
Mortality rates of thrombocytopenic groups gradually 
increased with the severity of the disease. 
The highest percentage of 20 (57.1%) of neonates with 
severe thrombocytopenia encounter death compared 
to moderate 32 (32.3%) and mild 4(15.4%) groups. The 
mortality rate among different thrombocytopenic 
groups was significantly different χ2-12.45; p-value 
0.002. Overall, 56 (35 %) neonates died, 53 (94.6%) had 
early-onset, and 3 (5.4 %) had late-onset.  
 
 
Table 1: Baseline demographic and clinical information of the study participant 
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Table 2: Means, gestational age, birth weight, platelet counts, and age at admission in Thrombocytopenia 
groups compared with Kruskal Wallis test 
Group No. Gestational 











Mild 26 39.4 ± 1.17 3.05 ± 0.14 105.2 ± 3.98 75.6 ± 28.5 <0.001 
Moderate 99 38.6 ± 1.20 2.77 ± 0.30 81.3 ± 12.34 53.3 ± 31.7 <0.001 
Severe 35 37.2 ± 1.57 2.52 ± 0.24 42.5 ± 4.26 27.4 ± 10.31 <0.001 
 
Table 3: Comparison of Categorical Risk Factors among different types of thrombocytopenia using Chi-square 
Test 
Risk Factors                             Groups χ2-value p-value 
  Group 1 Group 2 Group 3 Total 
Low Birthweight Yes 0 17 (58.6%) 12 (41.3%) 29 (18.1%) 15.64 <0.001  
 No 26 (19.8%) 82 (62.5%) 23 (17.5%) 131 (81.9%) 
Prematurity Yes 1 (4.3%) 9 (39.1%) 13 (56.2%) 23 (14.3%) 16.77 <0.001 
 No 25 (18.2%) 90 (65.6%) 22 (16.05) 137 (85.6%) 
Birth asphyxia Yes 6 (13.0%) 32 (69.5%) 8 (17.3%) 46 (28.7%) 1.65 0.438  
NS 
 No 20 (17.5%) 67 (58.7%) 27 (23.6%) 114 (71.2%) 
Gestational 
Hypertension 
Yes 8 (18.6%) 33 (76.4%) 2 (4.6%) 43(26.9%) 12.78 0.002 
 No 18 (15.3%) 66 (56.4%) 33 (28.2%) 117 (73.1%) 
Neonatal 
jaundice 
Yes 11 (47.8%) 11 (47.8%) 1 (4.3%) 23 (14.3%) 18.17 <0.001 
 No 15 (10.9%) 88 (64.2%) 34 (24.8%) 137 (85.6%) 
 
Table 4: Multivariate Binary Forward Logistic Regression Analysis 
Risk factors Odds ratio 95%CI p-value 
Prematurity 13.556 3.722, 49,36 <0.001 
Birth Asphyxia 39.229 11.867, 129.67 <0.001 
Low birth weight 6.909 1.935, 24.67 0.003 
 
Table 5: Comparison of mortality rates between Male and Female 
Groups                      Outcome 






Female  48 (67.6) 23 (32.4%) 0.382 0.618 
Male 56   (62.9) 33 (37.1 %)   
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Discussion 
 
Thrombocytopenia is the common hematological 
abnormality seen in NICU, often culminating in severe 
complications if not detected and managed properly. 
We observed that 61.9 % of the neonates had moderate 
NT and 21.9% had severe NT.  Our results are similar 
to Tirupathi et al14 who found 81% of the neonates 
suffering from moderate to severe thrombocytopenia 
but different from Rech et al, Von Lindern et al, 
khalessi et al and Gupta et al where the majority of the 
neonates had mild to moderate 
thrombocytopenia.4,15,16,17 
We had 83.1%of neonates with early onset of 
thrombocytopenia while only 16.5% were having a late 
onset of NT. Our results are similar to Bagale and 
Bhandari who reported 91.8% of neonates with early-
onset thrombocytopenia, and 8.2% with late-onset 
thrombocytopenia.18 Similarly, Jeremiah et al reported 
84.4% of the neonates with early-onset 
thrombocytopenia and 15.6% with late-onset 
thrombocytopenia.19 
Among the neonatal risk factors, our birth asphyxia 
rates of 28.8% were similar to Rech et al Bagale et al 
and Eslami et al4,18,20 who found neonatal asphyxia rate 
of 25%, 31.9%, and  35.1% respectively but different 
from Ulusoy et al and von Lindern et al who found 
asphyxia rate of 3-11%.11,15  
Prematurity is a well-known risk factor for developing 
NT.15,21 In the present study, 13 (56.2%) of premature 
neonates develop severe thrombocytopenia. Our 
findings are in line with those of Tirupathi et al 
Nandyal et al and Hanoudi.14,21,22  We had 29 (18.1%) 
low birth weight neonates in our study. Prematurity 
and low birth weight are highly correlated.  We like 
many other groups found a significant association of 
prematurity and low birth weight with NT.6,14,16,20,23 
Premature low birth weight neonates have limited 
capacity to undo the damage caused by enhanced 
destruction of platelets. Ig Gtransfer from Placental to 
fetal circulation rises with maturity. This process is 
hindered in premature, low birth weight neonates 
which make them vulnerable to NT.17 
Regarding the maternal risk factors contributing to 
NT, we observed that 14.4% of neonates had 
gestational hypertension. Our findings are in line with 
other groups14,16,23 but contrary to 46.4% reported by 
Eslami et al.20 
We like others found no difference in the incidence of 
thrombocytopenia in both genders.20,25,26,27 
We observed a mortality rate of 35% contrary to the 7–
10% rate reported by other groups.15,27 It can be 
ascribed to improper prenatal evaluation and 
enrollment in Gynea and Obs Department that further 
leads to problems with fetal evaluation and childbirth. 
Association of high mortality with severe 
thrombocytopenia can be taken as a prognostic marker 
to assess neonatal wellbeing. 
Impaired megakaryopoiesis, inadequate platelet 
production, and increased platelet destruction are the 
commonly incriminated pathophysiologic mechanism 
in NT. The underlying cause of NT can be delineated, 
to a greater extent, from the timing of the onset of 
thrombocytopenia. NT within 72 hrs of childbirth is 
usually due to fetal hypoxia as in infants born to 
mothers with gestational hypertension. NT due to 
sepsis and necrotizing enterocolitis presents after a 
few days of life and is usually severe.  An explained 
etiology of NT usually predicts an immune etiology. 
Bleeding risk is minimal in fetal hypoxia as compared 
to sepsis. The need for platelet transfusion varies in 




1- Neonatal thrombocytopenia is a reversible and 
treatable condition. Identification of associated 
risk factors and management to prevent severe 
bleeding and morbidity is important. 
2- Premature, low birth weight neonates having 
birth asphyxia were more prone to develop 
thrombocytopenia. 
3- Mortality is significantly associated with 
severe thrombocytopenia. Hence the degree of 
thrombocytopenia can be used as a prognostic 
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